Edogawa, Japan

Katsuhiko Okano

This inventor holds 3 USPTO granted patents. Top assignee: Daiichi Pharmaceutical Co., Ltd.. Active years: 2005-2007.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Katsuhiko Okano. Retrieved from https://idiyas.com/inventor/katsuhiko-okano

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


Average Co-Inventor Count = 9.0

ph-index = 1

Forward Citations = 3(Granted Patents)


Company Filing History:


Years Active: 2005-2007

Loading Chart...
3 patents (USPTO):Explore Patents

Title: Katsuhiko Okano: Innovator in Antibacterial Agent Production

Introduction

Katsuhiko Okano is a notable inventor based in Edogawa-ku, Japan. He has made significant contributions to the field of antibacterial agents, holding a total of 3 patents. His work focuses on innovative processes that enhance the production of essential compounds in this area.

Latest Patents

Okano's latest patents include a process for producing benzoxazine derivatives and production intermediates thereof. This process is crucial for developing antibacterial agents and includes the production of compound (VI-a) through a specific reaction schema. His work in this domain aims to provide efficient methods for creating effective antibacterial agents.

Career Highlights

Katsuhiko Okano is associated with Daiichi Pharmaceutical Co., Ltd., where he applies his expertise in pharmaceutical innovations. His career is marked by a commitment to advancing the production processes of vital medicinal compounds.

Collaborations

Throughout his career, Okano has collaborated with esteemed colleagues such as Kouji Sato and Yoshihiro Takayanagi. These partnerships have contributed to the successful development of his patented processes.

Conclusion

Katsuhiko Okano's contributions to the field of antibacterial agent production highlight his innovative spirit and dedication to improving healthcare solutions. His patents reflect a commitment to advancing pharmaceutical science and enhancing the efficacy of antibacterial treatments.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…